PI3′-Kinase Inhibition Forestalls the Onset of MEK1/2 Inhibitor Resistance in BRAF-Mutated Melanoma

類似資料

• Rational targeting of BRAF and PI3-Kinase signaling for melanoma therapy
  著者:: Deuker, Marian M., 等
  出版事項: (2015)
• Differential AKT dependency displayed by mouse models of BRAF(V600E)-initiated melanoma
  著者:: Marsh Durban, Victoria, 等
  出版事項: (2013)
• Targeting RAF kinases for cancer therapy: BRAF mutated melanoma and beyond
  著者:: Holderfield, Matthew, 等
  出版事項: (2014)
• Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK
  著者:: Tran, Khanh B., 等
  出版事項: (2021)
• Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
  著者:: Sweetlove, Melanie, 等
  出版事項: (2015)